Table 6.
Univariable analysis of risk factors associated with multidrug-resistance in genomic clusters.
| Non-cluster (n = 111) | Cluster (n = 38) | OR | 95% CI | P value | |
| Sex | |||||
| Male | 80 | 29 | 1.000 | ||
| Female | 31 | 9 | 1.249 | 0.531-2.936 | .61 |
| Age (yrs) | |||||
| 14-60 | 89 | 24 | 1.000 | ||
| ≥60 | 22 | 14 | 2.360 | 1.052-5.292 | .04 |
| Treatment history | |||||
| New case | 73 | 22 | 1.000 | ||
| Retreated | 38 | 16 | 0.716 | 0.337-1.521 | .39 |
| Positive sputum smear result | |||||
| No | 29 | 9 | 1.000 | ||
| Yes | 82 | 29 | 1.140 | 0.483-2.691 | .77 |
| Treatment outcome | |||||
| Cured or treatment completed | 58 | 16 | 1.000 | ||
| Treatment failed | 5 | 0 | 0.000 | 0.000 | .99 |
| Default, moved, or lost to follow-up | 24 | 11 | 1.661 | 0.673-4.099 | .27 |
| Died | 4 | 0 | 0.000 | 0.000 | .99 |
| Stop treatment due to drug-adverse-event | 4 | 4 | 3.625 | 0.815-16.122 | .09 |
| unknown | 16 | 7 | 1.586 | 0.557-4.516 | .39 |
| Beijing strains | |||||
| No | 5 | 2 | 1.000 | ||
| Yes | 106 | 36 | 1.178 | 0.219-6.337 | .85 |